Josol, Rax R.
HRN: 16-39-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2025
CEFTRIAXONE 1G (VIAL)
10/02/2025
10/17/2025
IV
750mg
Q12
S/p Wound Suturing; Closed Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes